Avery Therapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $19.5M

  • Investors
  • 1

Avery Therapeutics General Information

Description

Developer of immunomodulatory biologic therapeutics designed to treat diseases and injuries of human muscles. The company's advanced tissue-engineered heart graft contains multiple cell types implanted on the surface of a damaged heart, enabling patients to improve the blood flow of previously damaged tissues and improve heart function.

Contact Information

Website
www.averythera.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1501 North Campbell Avenue
  • Sarver Heart Center, Room 6154
  • Tucson, AZ 85724
  • United States
+1 (928)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Automation/Workflow Software
Therapeutic Devices
Vertical(s)
LOHAS & Wellness, Manufacturing, HealthTech, Life Sciences
Corporate Office
  • 1501 North Campbell Avenue
  • Sarver Heart Center, Room 6154
  • Tucson, AZ 85724
  • United States
+1 (928)

Avery Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avery Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series A) 25-Jul-2026 $19.5M Completed Generating Revenue
7. Secondary Transaction - Private 25-Jul-2026 Completed Startup
6. Grant 01-Jan-2019 Completed Startup
5. Accelerator/Incubator 23-Feb-2018 Completed Startup
4. Angel (individual) 01-Jun-2017 Completed Startup
3. Accelerator/Incubator 01-Jan-2017 Completed Startup
2. Grant 01-Jan-2016 $484K Completed Startup
1. University Spin-Out 01-Jan-2016 Completed Startup
To view Avery Therapeutics’s complete valuation and funding history, request access »

Avery Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A2
Series A1
Series A 2,358,383 $0.001000 $3.37 $3.37 1x $3.37 0%
To view Avery Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Avery Therapeutics Patents

  • 17

    Total Documents Applications and Grants

  • Total Patents Families

  • 8

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Avery Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3873549-A1 Compositions and methods for cryopreservation and reconstitution of engineered tissues Inactive 29-Oct-2018
EP-3873549-A4 Compositions and methods for cryopreservation and reconstitution of engineered tissues Inactive 29-Oct-2018
US-20210393853-A1 Compositions and methods for cryopreservation and reconstitution of engineered tissues Inactive 29-Oct-2018
WO-2020092321-A1 Compositions and methods for cryopreservation and reconstitution of engineered tissues Inactive 29-Oct-2018
US-20210386827-A1 Cell-free compositions and methods for restoration or enhancement of tissue function Inactive 15-Oct-2018 A61K38/2053
To view Avery Therapeutics’s complete patent history, request access »

Avery Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Avery Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bija Ventures Venture Capital Minority
To view Avery Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Avery Therapeutics FAQs

  • When was Avery Therapeutics founded?

    Avery Therapeutics was founded in 2016.

  • Where is Avery Therapeutics headquartered?

    Avery Therapeutics is headquartered in Tucson, AZ.

  • What is the size of Avery Therapeutics?

    Avery Therapeutics has 9 total employees.

  • What industry is Avery Therapeutics in?

    Avery Therapeutics’s primary industry is Drug Discovery.

  • Is Avery Therapeutics a private or public company?

    Avery Therapeutics is a Private company.

  • What is the current valuation of Avery Therapeutics?

    The current valuation of Avery Therapeutics is .

  • What is Avery Therapeutics’s current revenue?

    The current revenue for Avery Therapeutics is .

  • How much funding has Avery Therapeutics raised over time?

    Avery Therapeutics has raised $20M.

  • Who are Avery Therapeutics’s investors?

    Bija Ventures has invested in Avery Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process